<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[pharmaceutical company and strategy Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/pharmaceutical+company+and+strategy.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to pharmaceutical company and strategy]]></description>
	<s:counts start="0" returned="20" found="62" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Pharma Roundup: Novo Nordisk's Growth Strategy, Disclosure at Cleveland and Penn, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000471/pharma-roundup-novo-nordisks-growth-strategy-disclosure-at-cleveland-and-penn-and-more/]]></link>
		<description><![CDATA[Novo Nordisk is looking for growth in the developed world. The Cleveland Clinic and the hospital at Penn announced disclosure policies this week. The UK biotech industry is worried. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 05 Dec 2008 17:55:28 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/forbes.html"><![CDATA[Forbes]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
	</item>
	<item>
		<title><![CDATA[Bristol-Myers Squibb Plans $2.5 Bil. in Layoffs, Cuts]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000386/bristol-myers-squibb-plans-25-bil-in-layoffs-cuts/]]></link>
		<description><![CDATA[Bristol-Myers Squibb made a presentation this morning at the Credit Suisse Healthcare Conference that showed CFO John Marc-Huet wants to save the company $2.5 billion in "productivity initiatives." He's going to squeeze these out of "headcount and related costs" -- which sounds like a euphemism for layoffs.   ...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 13 Nov 2008 12:47:18 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/layoff.html"><![CDATA[Layoff]]></category>
		<category domain="http://resources.bnet.com/topic/foreign-exchange.html"><![CDATA[Foreign-exchange]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/john+marc-huet.html"><![CDATA[John Marc-Huet]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/currency+%2526+foreign+exchange.html"><![CDATA[Currency & Foreign Exchange]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="tickers">BMY</category>
	</item>
	<item>
		<title><![CDATA[Corporate Espionage Allegations Reveal Storm in a Teacup at Pharma Conference]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000233/corporate-espionage-allegations-reveal-storm-in-a-teacup-at-pharma-conference/]]></link>
		<description><![CDATA[There was a behind-the-scenes drama at the Pharma Competitive Intelligence conference in New Jersey last week involving allegations that the organizer of the conference engaged in "misappropriation of company assets" and that subpoenas have been sent to Pfizer, Johnson & Johnson, Sanofi-Aventis, Merck, Novartis, and Bristol-Myers Squibb.   ...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 23 Sep 2008 09:08:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/conference.html"><![CDATA[Conference]]></category>
		<category domain="http://resources.bnet.com/topic/tools+%2526+techniques.html"><![CDATA[Tools & Techniques]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Would You Logroll for the Boss?]]></title>
		<link><![CDATA[http://blogs.bnet.com/ethics/?p=219]]></link>
		<description><![CDATA[Where's the line when it comes to kissing up? As BNET Pharma Industry blogger Jim Edwards pointed out this week, when GlaxoSmithKline SVP of managed markets and neurohealth, Stephen Stefano, came out recently with a new management book (called "Passion and Ice,") a group of company and pharma industry colleagues...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 15 Aug 2008 11:00:43 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/michael+mattis.html"><![CDATA[Michael Mattis]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
	</item>
	<item>
		<title><![CDATA[Harris Poll: Is Your Industry Loved or Loathed?]]></title>
		<link><![CDATA[http://blogs.bnet.com/bnet1/?p=526]]></link>
		<description><![CDATA[  	The Find: An annual poll reveals which industries are rising in public esteem and which are tanking.  	The Source: The Harris Poll's annual survey of public attitudes to twenty industries.    The Takeaway: Every year Harris asks 1,000 American adults for their views on whether...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 07 Aug 2008 09:09:36 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/jessica+stillman.html"><![CDATA[jessica stillman]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[management]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[strategy]]></category>
	</item>
	<item>
		<title><![CDATA[High Performance In Sight: Pharmaceutical Company Saves Money By Streamlining IT Infrastructure]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=1181163]]></link>
		<description><![CDATA[To sustain revenues in a competitive market and invest more aggressively in research and development, one of the world's largest pharmaceutical companies made a strategic decision to reduce US$100 million from its IT budget. IT standardization was the first item on the agenda. Accenture marshalled a team from Accenture Technology...]]></description>
		<s:doctype><![CDATA[Case studies]]></s:doctype>
		<pubDate>Wed, 23 Jul 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/it+infrastructure.html"><![CDATA[IT Infrastructure]]></category>
		<category domain="http://resources.bnet.com/topic/information+technology.html"><![CDATA[Information Technology]]></category>
		<category domain="http://resources.bnet.com/topic/accenture+ltd..html"><![CDATA[Accenture Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/high-performance.html"><![CDATA[High-performance]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/itil.html"><![CDATA[ITIL]]></category>
		<category domain="http://resources.bnet.com/topic/process+improvement.html"><![CDATA[Process Improvement]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/it+services.html"><![CDATA[It Services]]></category>
		<category domain="http://resources.bnet.com/topic/quality.html"><![CDATA[Quality]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACN</category>
		<category domain="tickers">ACN</category>
	</item>
	<item>
		<title><![CDATA[Man Bites Dog: Former Merck CEO Blasts High Drug Prices]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/100058/man-bites-dog-former-merck-ceo-blasts-high-drug-prices/]]></link>
		<description><![CDATA[Most pharmaceutical companies insist that high drug prices are a natural consequence of the risky business of drug discovery, and that huge profits on marketed drugs are necessary to cover the costs of the 5,000 to 10,000 experimental drugs that fail for every one that succeeds. In fact, there are...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 05 May 2008 01:59:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/pricing.html"><![CDATA[Pricing]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Pharmaceutical Jobs Offer Good Pay]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=375984]]></link>
		<description><![CDATA[Pharmaceutical jobs belong in the healthcare industry, a fast growing industry. An aging population and new developments in diagnosis and treatment leading to increased use of medication are the main factors leading this growth. The pharmaceutical industry itself is a big part of this growth story. In addition to bringing...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Tue, 01 Jan 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/job.html"><![CDATA[Job]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
	</item>
	<item>
		<title><![CDATA[Products & Services: Strategy Science For Pharma Sales Force Management]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=335029]]></link>
		<description><![CDATA[How well do you believe your sample allocation plan is meeting your business objectives? Is your investment in sampling generating the increased revenue and market share that you think it should? Are you confident that you're not over-sampling and cannibalizing your market? With Fair Isaac's Strategy Science for Pharmaceutical Sampling,...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Mon, 01 Jan 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/sales+force.html"><![CDATA[Sales Force]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/allocation.html"><![CDATA[Allocation]]></category>
		<category domain="http://resources.bnet.com/topic/fair+isaac.html"><![CDATA[Fair Isaac]]></category>
		<category domain="http://resources.bnet.com/topic/strategy+science.html"><![CDATA[Strategy Science]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
	</item>
	<item>
		<title><![CDATA[In the interest of the patient: Convergence across the pharmaceutical and healthcare industries]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=332876]]></link>
		<description><![CDATA[While the pharmaceutical industry is seeking to replace the blockbuster model of drug development, healthcare is struggling with rapidly rising costs. This paper explores how, by collaborating and sharing data, the two industries can realize the full value of the information they collect--and improve patient treatments.   ]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Mon, 11 Dec 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/convergence.html"><![CDATA[Convergence]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
	</item>
	<item>
		<title><![CDATA[Accenture Electronic Production Execution System: Enhancing Compliance And Performance]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=1181155]]></link>
		<description><![CDATA[Quality, price and time to market have always been the driving factors for operational excellence in manufacturing. Increasingly stringent regulations, increased competition created by globalization, shrinking drug pipelines and rising reimbursement favoring generic drugs have been adding pressure to pharmaceutical manufacturing's costs and regulatory compliance. To achieve high performance against...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Sun, 10 Dec 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/performance.html"><![CDATA[Performance]]></category>
		<category domain="http://resources.bnet.com/topic/accenture+ltd..html"><![CDATA[Accenture Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/compliance.html"><![CDATA[Compliance]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/manual+data+management.html"><![CDATA[Manual Data Management]]></category>
		<category domain="http://resources.bnet.com/topic/globalization.html"><![CDATA[Globalization]]></category>
		<category domain="http://resources.bnet.com/topic/data+management.html"><![CDATA[Data Management]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/regulations.html"><![CDATA[Regulations]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACN</category>
		<category domain="tickers">ACN</category>
	</item>
	<item>
		<title><![CDATA[Auriga Files Advanced Drug-Delivery Patent Application to Significantly Expand Revenues from Proprietary Drug Brands; Platform Technology Strengthens Company's Strategy to Extend Brand Exclusivity in Multibillion-Dollar Pharmaceutical Markets]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Sept_15/ai_n16728252]]></link>
		<description><![CDATA[NORCROSS, Ga. -- Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company driving high-growth revenues through acquisition of valuable brand portfolios and innovative drug development programs, today announced the filing of a new provisional patent application for a key platform technology that will provide market exclusivity of its proven pharmaceutical brands.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 15 Sep 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/brand.html"><![CDATA[brand]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[strategy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Valuing R&D Projects In A Portfolio: Evidence From The Pharmaceutical Industry]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=321671]]></link>
		<description><![CDATA[Understanding the value of a product development project is central to a firm's choice of project portfolio. This is due to interactions with other projects in the portfolio that address the same consumer need and with other projects that require the same development resources. This paper empirically investigates the structure...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Sat, 01 Jul 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/portfolio.html"><![CDATA[Portfolio]]></category>
		<category domain="http://resources.bnet.com/topic/product+development.html"><![CDATA[Product Development]]></category>
		<category domain="http://resources.bnet.com/topic/product+marketing.html"><![CDATA[Product Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/r%2526d.html"><![CDATA[R&D]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+pennsylvania.html"><![CDATA[University Of Pennsylvania]]></category>
	</item>
	<item>
		<title><![CDATA[Pressure Points: Risk Management in the Pharmaceuticals Industry]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=151558]]></link>
		<description><![CDATA[The report highlights the fact that the pharmaceutical industry is as much as 50 percent riskier than the rest of the S&P 500. Pharmaceutical companies have risk management programs in place and a "controls culture" from being in a highly regulated industry. But their risk management frameworks may not have...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Mon, 19 Sep 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/financial+planning.html"><![CDATA[Financial Planning]]></category>
		<category domain="http://resources.bnet.com/topic/financial+services.html"><![CDATA[Financial Services]]></category>
		<category domain="http://resources.bnet.com/topic/kpmg+international.html"><![CDATA[KPMG International]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/risk+management.html"><![CDATA[Risk Management]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[Security]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
	</item>
	<item>
		<title><![CDATA[Critical Factors for Alliance Formation: Insights From the Deloitte Research Biotech Alliance Survey]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=152365]]></link>
		<description><![CDATA[Convergence of traditional markets and technological platforms is forcing big pharma and big biopharma companies to compete head-to-head in forming alliances with the small biotech companies that now account for a growing share of new drugs in clinical trials. As the level of collaboration increases, alliance formation is becoming more...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Thu, 30 Jun 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/alliance.html"><![CDATA[Alliance]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/deloitte+touche+tohmatsu.html"><![CDATA[Deloitte Touche Tohmatsu]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
	</item>
	<item>
		<title><![CDATA[Critical Factors For Alliance Formation]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=953631]]></link>
		<description><![CDATA[Convergence of traditional markets and technological platforms is forcing big pharma and big Biopharma companies to compete head-to-head in forming alliances with the small biotech companies that now account for a growing share of new drugs in clinical trials. As the level of collaboration increases, alliance formation is becoming more...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Thu, 30 Jun 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/alliance.html"><![CDATA[Alliance]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/deloitte+touche+tohmatsu.html"><![CDATA[Deloitte Touche Tohmatsu]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
	</item>
	<item>
		<title><![CDATA[Recapturing the Vision: Integrity Driven Performance in the Pharmaceutical Industry]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=147713]]></link>
		<description><![CDATA[Over the last few years, pharmaceutical companies have seen an increasing level of regulatory scrutiny and highly critical media coverage of the industry's R&D, marketing and manufacturing practices. As a result, there has been a noticeable decline in consumer and investor confidence and a growing degree of negative perceptions about...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Wed, 29 Jun 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/performance.html"><![CDATA[Performance]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/pricewaterhousecoopers+llp.html"><![CDATA[PricewaterhouseCoopers LLP]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/vision.html"><![CDATA[Vision]]></category>
	</item>
	<item>
		<title><![CDATA[The Influence of the Pharmaceutical Industry]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=138494]]></link>
		<description><![CDATA[The interests of pharmaceutical companies and those of the public, patients and the NHS often overlap but they are not identical. For the industry, medical need must be combined with the likelihood of a reasonable return on investment. An effective regulatory regime to ensure that the industry works in the...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Tue, 22 Mar 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
	</item>
	<item>
		<title><![CDATA[Robert Bazell, Chief Medical and Science Correspondent, NBC News, to Discuss Strategies for Enhancing Pharma's Image and Public Perception]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_March_10/ai_n12416859]]></link>
		<description><![CDATA[NEW YORK -- With the increased scrutiny on pharmaceutical companies due to drug recalls and safety alerts, the public image of the pharmaceutical industry has been tarnished. Robert Bazell, Chief Medical and Science Correspondent, NBC News, will discuss strategies for enhancing the industry's image and public perception through effective media...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 10 Mar 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/robert+bazell.html"><![CDATA[Robert Bazell]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[strategy]]></category>
		<category domain="http://resources.bnet.com/topic/nbc+universal+inc..html"><![CDATA[NBC Universal Inc.]]></category>
	</item>
	<item>
		<title><![CDATA[Rethinking Innovation In Pharmaceutical R&D]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=953351]]></link>
		<description><![CDATA[The pharmaceutical industry is facing a challenge to be productive. One of the solutions to this problem is for the industry to better harness innovation to deliver more and better drugs through the pipeline. But what is innovation and how can it deliver higher performance through more valuable drugs? Historically,...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Wed, 02 Feb 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/innovation.html"><![CDATA[Innovation]]></category>
		<category domain="http://resources.bnet.com/topic/r%2526d.html"><![CDATA[R&D]]></category>
		<category domain="http://resources.bnet.com/topic/accenture+ltd..html"><![CDATA[Accenture Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/leadership.html"><![CDATA[Leadership]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACN</category>
		<category domain="tickers">ACN</category>
	</item>
</channel>
</rss>
